A Study of the Interaction of Rifampin and Vinflunine in Subjects With Advanced Cancer

Withdrawn before enrolling · Phase 1

Conditions studied: Cancer

In brief

The purpose of this study is to test how vinflunine interacts with rifampin in the human body

Key facts

Study ID

NCT00534807

Run by

Bristol-Myers Squibb

People needed

0

Starts

2007-09-01

Expected to finish

2008-11-01

Last updated by the study team

2015-09-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Cancer unresponsive to previous treatment
• Consent for genetic samples

You may not qualify if…

• Cancer of the blood
• Spread of cancer to the brain
• Moderate or severe nerve damage
• Low white blood cell counts and platelet counts
• Inadequate liver or kidney function
• Prior treatment with vinflunine
• Use of certain medications that might interfere with the metabolism of vinflunine

Where it is running

• Local Institution — Detroit, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.